lenalidomide,daratumumab,pomalidomide,ciltacabtagene autoleucel,dexamethasone,bortezomib
janssen
['multiplemyeloma', 'lenalidomide', ' lena', 'cartitude', 'cartitude-4', 'janssen']
for us #hcps attending #eha2023, tune in to dr. hermann einsele s ( ) presentation on first results from the phase 3 cartitude-4 study evaluating a bcma car-t therapy in patients with relapsed and lenalidomide-refractory #multiplemyeloma.
Dedicated to sharing Janssen Oncology scientific communications for US HCPs. Account run by Janssen Global Services LLC. Review our Guidelines: https://t.co/uieWByQjn3.